[Event Report] WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis” (September 25, 2021)
date : 4/13/2022
Tags: AMR
*A video of the Symposium has been published on April 13, 2022.
*A report on the Symposium has been published on April 2, 2022.
AMR Alliance Japan (Secretariat: Health and Global Policy Institute) hosted a WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis”
Antimicrobial resistance (AMR) occurs when the microorganisms that cause infectious disease grow resistant over time to the antimicrobials used to treat them. If not enough is done to combat this problem, it is estimated that AMR will cause more deaths than cancer by 2050. Urgent action is needed.
In celebration of the 72nd session of the WHO Regional Committee for the Western Pacific to be held in Himeji in October, this symposium shared the current state of AMR-related issues within Japan and overseas, and discussed future countermeasures.
You can watch the day’s proceedings below.
[Overview]
■Date and Time: Saturday, September 25, 2021, from 16:00-18:00 JST
■Language: Japanese and English (Simultaneous Interpretation will be available)
■Venue:
– Online Participation (Zoom Webinar)
– Himeji Venue
■Participation fee: Free
■Organizers: AMR Alliance Japan, Himeji City, Himeji Medical Association, Himeji Dental Association
■Supported by: Ministry of Health, Labour and Welfare (TBD), Himeji Pharmacist Association, Hyogo Nursing Association Seiban Branch
■Sponsor: Japan Pharmaceutical Manufacturers Association
[Program] (Titles Omitted)
15:50-15:55 Greetings (For Himeji Venue Only)
Etsuji Ishibashi (Chairman, Himeji Medical Association)
16:00-16:05 Opening Remarks and Introduction
Ryoji Noritake (CEO, Boad Member, Health and Global Policy Institute)
16:05-16:25 Message
Takeshi Kasai (Regional Director for the Western Pacific, World Health Organization (WHO) )
Yasuhisa Shiozaki (Member of the House of Representatives; Former Minister of Health, Labour and Welfare; Member, Global Leaders Group on Antimicrobial Resistance; Chairman, Special Mission Committee on Data Health Advancement, Liberal Democratic Party of Japan(LDP))
Shigeru Omi (President, Japan Community Health care Organization (JCHO); Chairperson, Committee for the Promotion of Pandemic Influenza and New Infectious Disease Preparedness and Response)
16:25-16:40 Lecture 1 “AMR as a Global Health Crisis: A message from the United Kingdom”
Dame Sally Davies (UK Special Envoy on Antimicrobial Resistance)
16:40-16:55 Lecture 2 “AMR in Japan and Expectations toward Future”
Norio Ohmagari (Disease Control and Prevention Center, National Center for Global Health and Medicine (NCGM); Director, AMR Clinical Reference Center, NCGM)
16:55-17:55 Panel Discussion: Antimicrobial Stewardship
Panelists:
Socorro Escalante (Regional Coordinator for the programme on Essential Medicines and Health Technologies (EMT) and antimicrobial resistance (AMR), Western Pacific Regional Office, WHO)
Norio Ohmagari (Disease Control and Prevention Center, National Center for Global Health and Medicine (NCGM); Director, AMR Clinical Reference Center, NCGM)
Testuji Kawamura (Director, NHO Himeji Medical Center)
Kyoko Ama (Representative, Children and Healthcare Project; Fellow, Health and Global Policy Institute)
Takeshi Enami (Director, Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare)
Hajime Inoue (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)
Tetsuya Ito (Chair, International Affairs Committee, Japan Pharmaceutical Manufacturers Association)
Moderator:
Ryoji Noritake (CEO, Boad Member, Health and Global Policy Institute)
17:55 -18:00 Closing Remarks
Hideyasu Kiyomoto (Mayor of Himeji City)
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
Featured Posts
-
2024-04-18
[Event Report] NCDs-related Cross-project Meeting: The 2nd Meeting on Non-Communicable Disease in Hokkaido and Tohoku (March 15, 2024)
-
2024-04-22
[Activity Report] Health Information Project Global Sage Meetings for “Co-creating Health Information Right” (April 22, 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-24
[Public Comment Submission] “The Sixth Basic Environment Plan (Draft)” (April 10, 2024)